Cingulate (CINGW) Total Debt (2022 - 2026)
Cingulate's (CINGW) quarterly Total Debt came in at $5.1 million in Q2 2026, down 31.96% quarter-over-quarter from $7.4 million in Q4 2025.
Analysis
Cingulate (CINGW) Total Debt (2022 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Total Debt for 5 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Debt changed N/A year-over-year to $5.1 million; the trailing twelve-month figure through Jun 2026 stood at $5.1 million (changed N/A YoY), and the FY2025 full-year result was $7.4 million, up 50.03% from the prior year.
- Total Debt declined to $5.1 million in Q2 2026 per CINGW's latest filing, from $7.4 million in the prior quarter.
- Across five years, Total Debt topped out at $8.0 million in Q2 2023 and bottomed at $3.2 million in Q3 2025.
- Historically, Total Debt has averaged $5.4 million across 5 years, with a median of $5.0 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Total Debt decreased 2.67% in 2024, then surged 50.03% in 2025.
- Over 5 years, Total Debt stood at $5.0 million in 2022, then rose by 2.0% to $5.1 million in 2023, then retreated by 2.67% to $5.0 million in 2024, then soared by 50.03% to $7.4 million in 2025, then slumped by 31.96% to $5.1 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $5.1 million, $7.4 million, and $3.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 60.73 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 63.19 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 25.19 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 38.81 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 5.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.07 Mn |
| Dec 31, 2025 | 7.45 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Dec 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 8.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 5.00 Mn |